< Back to all clusters
[HEALTH] · Canada · 42 sources

started · updated

B.C. government partners with UBC and McGill for rare disease gene therapy

The British Columbia Ministry of Health has announced a partnership with the University of British Columbia and McGill University to develop a personalized gene-editing therapy. The initiative aims to treat Gurmoh, a three-year-old boy from Surrey, who is battling a rare and progressive neurodegenerative disease known as spastic paraplegia.

Gurmoh’s condition is caused by a de novo mutation, which is not present in either parent. The disease affects the nerves in the spinal cord that control movement, leading to progressive muscle stiffness, speech difficulties, and leg weakness. Gurmoh is reported to be the only known case of this specific disease in Canada.

The announcement follows extensive community fundraising efforts by Gurmoh’s parents, Stalin and Navpreet Gill, who raised over $2.7 million to fund the creation of the therapy. The family had previously met with health officials to discuss potential provincial funding for the treatment.

Entities

British Columbia Ministry of Health · Gurmoh Gill · McGill University · Surrey, British Columbia · University of British Columbia

Claims

What the coverage asserts, and how many sources carry each claim.

Sources